Wissenschaftl. Titel | A Randomised, Double-Blind, Placebo-Controlled Phase 3 Clinical Trial to Assess the Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adult and Adolescent Patients With Moderate-To-Severe Atopic Dermatitis That Are Not Adequately Controlled With Cyclosporine or For Whom Cyclosporine is Not Medically Advisable |
Erkrankung |
Haut:
Ekzem (Dermatitis):
Neurodermitis (Atopische Dermatitis)
|
weitere Prüfzentren | |
Kurzprotokoll | Kurzprotokoll |
Links | Zu den Ein- und Ausschlusskriterien |
erstellt 20.01.2022 Student Studienregister
geändert 25.04.2023 Student Studienregister